Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT

Bone Marrow Transplantation

Volumn 40, Issue 8, 2007, Pages 723-728

  Park, M J ^a   Choi, H B ^a   Jang, J P ^a   Kim, H J ^a   Kim, Y J ^a   Eom, K S ^a   Lee, S ^a   Kim, D W ^a   Lee, J W ^a   Min, W S ^a   Kim, C C ^a   Kim, T G ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC INCOMPATIBILITY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; INFANT; KOREA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T CELL DEPLETION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KOREA; LEUKEMIA; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASM PROTEINS; OLIGOPEPTIDES; TISSUE DONORS;

EID: 34948895517     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705808     Document Type: Article

References (23)

1. Mullighan C, Heatley S, Doherty K, Szabo F, Grigg A, Hughes T et al. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 2004; 77: 587-596.
2. Spierings E, Wieles B, Goulmy E. Minor histocompatibility antigens - big in tumor therapy. Trends Immunol 2004; 25: 56-60.
3. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y. Lancet 1976; 2: 1206.
4. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches for minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft versus host disease after bone marrow transplantation. N Engl J 1996; 334: 281-285.
5. Warren EH, Gavin M, Greenberg PD, Riddell SR. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Curr Opin Hematol 1998; 5: 429-433.
6. Akatsuka Y, Warren EH, Gooley TA, Brickner AG, Lin MT, Hansen JA et al. Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling. Br J Haematol 2003; 123: 671-675.
7. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054-1057.
8. Mommaas B, Kamp J, Drijfhout JW, Beekman N, Ossendorp F, Van Veelen P et al. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 Locus. J Immunol 2002; 169: 3131-3136.
9. Pierce RA, Field ED, Mutis T, Golovina TN, Von Kap-Herr C, Wilke M et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223-3230.
10. Brickner AG, Warren EH, Caldwell JA, Akatsuka Y, Golovina TN, Zarling AL et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001; 193: 195-206.
11. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ et al. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46 355-367.
12. Murata M, Emi N, Hirabayashi N, Hamaguchi M, Goto S, Wakita A et al. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients. Int J Hematol 2000; 72: 371-375.
13. Pietz BC, Warden MB, DuChateau BK, Ellis TM. Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol 2005; 66 1174-1182.
14. Arostegui JI, Gallardo D, Rodriguez-Luaces M, Querol S,. Madrigal JA, Garcia-Lopez J et al. Genomic typing of minor histocompatibility antigen HA-1 by reference strand mediated conformation analysis (RSCA). Tissue Antigens 2000; 56: 69-76.
15. Di Terlizzi S, Zino E, Mazzi B, Magnani C, Tresoldi C, Perna SK et al. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations. Biol Blood Marrow Transplant 2006; 12: 95-101.
16. Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742-2747.
17. Spierings E, Goulmy E. Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005; 115: 3397-3400.
18. Gallardo D, Arostegui JI, Balas A, Torres A, Caballero D, Carreras E et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (QvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931-936.
19. Choi HB, Kim TG, Chung TJ, Han H. The distribution of HLA-A*02 subtype in Koreans. Korean J Immunol 1998; 20: 31-37.
20. Del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995; 154: 685-693.
21. Nesci S, Buffi O, Iliescu A, Andreani M, Lucarelli G. Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients. Bone Marrow Transplant 2003; 31: 575-579.
22. Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, Smith AG et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999; 94: 2911-2914.
23. Rufer N, Wolpert E, Heig C, Tiercy JM, Gratwohl A, Chapuis B et al. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 1998; 66: 910-916.